Polarityte is a biotechnology & medical research business based in the US. Polarityte shares (PTE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.07 – the same closing value as a week prior. Polarityte employs 42 staff and has a trailing 12-month revenue of around $73,000.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.07 |
|---|---|
| 52-week range | $0.00 - $0.00 |
| 50-day moving average | $0.35 |
| 200-day moving average | $0.62 |
| Wall St. target price | $0.80 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.58 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.0666 from 2023-08-17
| 1 week (2024-10-05) | N/A |
|---|---|
| 1 month (2024-09-12) | N/A |
| 3 months (2024-07-12) | N/A |
| 6 months (2024-04-12) | N/A |
| 1 year (2023-10-12) | N/A |
|---|---|
| 2 years (2022-10-14) | -91.41% |
| 3 years (2021-10-15) | 0.5853 |
| 5 years (2019-10-16) | 3.11 |
| Revenue TTM | $73,000 |
|---|---|
| Gross profit TTM | $198,000 |
| Return on assets TTM | -56.67% |
| Return on equity TTM | -54.97% |
| Profit margin | 0% |
| Book value | $1.74 |
| Market Capitalization | $1.8 million |
TTM: trailing 12 months
We're not expecting Polarityte to pay a dividend over the next 12 months.
Polarityte's shares were split on a 1:25 basis on 16 May 2022. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Polarityte shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Polarityte shares which in turn could have impacted Polarityte's share price.
Over the last 12 months, Polarityte's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Polarityte's is 1.1518. This would suggest that Polarityte's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
PolarityTE, Inc. , a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.
Read our beginner’s guide to trading options in the US.